MoneyWorks4Me

Concord Biotech - Quaterly Results

14 Nov 2025 Evaluate
A decrease in the sales to Rs. 2470.58 millions was observed for the quarter ended September 2025. The sales stood at Rs. 3101.81 millions during the similar quarter previous year.The Company to register a -36.28%  fall in the net profit for the quarter ended September 2025.The Operating Profit of the company witnessed a decrease to 1039.66 millions from 1467.04 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 2470.58 3101.81 -20.35 4510.46 5259.83 -14.25 12000.87 10169.39 18.01
Other Income 134.29 100.26 33.94 271.07 203.34 33.31 444.47 337.80 31.58
PBIDT 1039.66 1467.04 -29.13 1790.41 2382.90 -24.86 5507.79 4653.36 18.36
Interest 0.59 0.96 -38.54 1.18 3.37 -64.99 5.29 25.52 -79.27
PBDT 1039.07 1466.08 -29.13 1789.23 2379.53 -24.81 5502.50 4627.84 18.90
Depreciation 183.90 133.14 38.13 361.66 264.92 36.52 543.74 535.92 1.46
PBT 855.17 1332.94 -35.84 1427.57 2114.61 -32.49 4958.76 4091.92 21.18
TAX 226.21 345.94 -34.61 372.95 545.22 -31.60 1229.11 1044.62 17.66
Deferred Tax 6.25 5.35 16.82 12.21 10.69 14.22 39.50 46.28 -14.65
PAT 628.96 987.00 -36.28 1054.62 1569.39 -32.80 3729.65 3047.30 22.39
Equity 104.62 104.62 0.00 104.62 104.62 0.00 104.62 104.62 0.00
PBIDTM(%) 42.08 47.30 -11.03 39.69 45.30 -12.38 45.89 45.76 0.30
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..